KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Times Interest Earned (2019 - 2025)

Historic Times Interest Earned for Esperion Therapeutics (ESPR) over the last 7 years, with Q3 2025 value amounting to -$0.45.

  • Esperion Therapeutics' Times Interest Earned rose 5749.68% to -$0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.37, marking a year-over-year decrease of 23184.59%. This contributed to the annual value of $0.92 for FY2024, which is 13480.87% up from last year.
  • Latest data reveals that Esperion Therapeutics reported Times Interest Earned of -$0.45 as of Q3 2025, which was up 5749.68% from $0.35 recorded in Q2 2025.
  • Esperion Therapeutics' 5-year Times Interest Earned high stood at $5.15 for Q1 2024, and its period low was -$10.19 during Q1 2021.
  • Over the past 5 years, Esperion Therapeutics' median Times Interest Earned value was -$2.81 (recorded in 2023), while the average stood at -$2.2.
  • In the last 5 years, Esperion Therapeutics' Times Interest Earned skyrocketed by 25253.5% in 2024 and then plummeted by 12206.67% in 2025.
  • Esperion Therapeutics' Times Interest Earned (Quarter) stood at -$4.14 in 2021, then rose by 28.37% to -$2.97 in 2022, then increased by 5.16% to -$2.81 in 2023, then skyrocketed by 90.43% to -$0.27 in 2024, then tumbled by 67.8% to -$0.45 in 2025.
  • Its last three reported values are -$0.45 in Q3 2025, $0.35 for Q2 2025, and -$1.14 during Q1 2025.